89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in 89bio, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ETNB is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025
- Institutional holders
- 0
- −2 vs. Q4 2025
- Shares held
- 0
- −90.0K (−100.0%) vs. Q4 2025
- Total value
- $0
- −$1.11M (−100.0%) vs. Q4 2025
- New holders
- 0
- 0 more added
- Sold out
- 2
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 2 | $1.11M |
| Q3 2025 | 198 | $2.27B |
| Q2 2025 | 185 | $1.58B |
| Q1 2025 | 187 | $1.14B |
| Q4 2024 | 156 | $948.7M |
| Q3 2024 | 144 | $773.8M |
| Q2 2024 | 145 | $828.4M |
| Q1 2024 | 150 | $1.14B |
| Q4 2023 | 153 | $1.05B |
| Q3 2023 | 160 | $1.11B |
| Q2 2023 | 157 | $1.46B |
| Q1 2023 | 147 | $1.08B |
| Q4 2022 | 106 | $589.5M |
| Q3 2022 | 86 | $227.3M |
| Q2 2022 | 70 | $104.6M |
| Q1 2022 | 69 | $64.3M |
| Q4 2021 | 50 | $226.1M |
| Q3 2021 | 48 | $339.4M |
| Q2 2021 | 49 | $315.2M |
| Q1 2021 | 67 | $400.6M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding 89bio, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −17−100.0% | Sold out |